echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > Adjustment of the regulatory layout of Fujian ephedrine in place

    Adjustment of the regulatory layout of Fujian ephedrine in place

    • Last Update: 2013-08-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the spirit of the notice on adjusting the distribution of regional wholesale enterprises of narcotic drugs and class I psychotropic drugs issued by the State Food and drug administration, in the first half of this year, Fujian food and Drug Administration cancelled the designated operation qualification of five enterprises, added three new designated enterprises, further standardized the operation order of narcotic drugs, and effectively guaranteed the medical demand It is understood that Fujian Provincial Bureau has formulated the adjustment plan for regional wholesale enterprises of narcotic drugs and class I psychotropic drugs in Fujian Province, which divides the adjustment work into four stages: investigation and investigation, organization and application, preparation or rectification, inspection and acceptance, and comprehensive evaluation According to the business scale, the coverage of medical institutions, the distribution of basic drugs, the conditions of warehousing, logistics and distribution, the level of information management and other indicators, combined with daily supervision, drug safety credit rating, management and operation experience of special drugs and drug precursor chemicals, 22 designated wholesale enterprises have been reconfirmed based on the principle of "promoting moderate competition and improving drug supply environment" At the same time, dispatched supervisors to go deep into the enterprise to guide the hardware construction and software construction on site At present, these 22 designated enterprises of narcotic drugs and class I psychotropic drugs have passed inspection, acceptance, comprehensive evaluation and approval.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.